Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report.
10.1016/j.joim.2020.11.005
- Author:
Na ZHI
1
;
Qian MO
2
;
Shuo YANG
3
,
4
;
Yuan-Xing QIN
1
;
Hao CHEN
1
;
Zeng-Guang WU
5
;
Cai-Hong LAN
5
;
Jun ZHANG
1
;
Yin-Long LI
6
Author Information
1. Guizhou University of Traditional Chinese Medicine, Guiyang 550002, Guizhou Province, China.
2. Guizhou University of Traditional Chinese Medicine, Guiyang 550002, Guizhou Province, China. Electronic address: duoduo425@126.com.
3. Guizhou University of Traditional Chinese Medicine, Guiyang 550002, Guizhou Province, China
4. The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang 550001, Guizhou Province, China.
5. The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang 550001, Guizhou Province, China.
6. China Academy of Chinese Medical Sciences, Beijing 100700, China. Electronic address: weiming050@163.com.
- Publication Type:Research Support, Non-U.S. Gov't
- Keywords:
Corona virus disease 2019;
Exudation;
Inflammation;
Pulmonary fibrosis;
Traditional Chinese medicine
- MeSH:
Administration, Oral;
COVID-19/virology*;
Drugs, Chinese Herbal/therapeutic use*;
Exudates and Transudates;
Female;
Humans;
Inflammation/etiology*;
Lung/pathology*;
Magnoliopsida;
Medicine, Chinese Traditional;
Middle Aged;
Phytotherapy;
Pulmonary Fibrosis/etiology*;
SARS-CoV-2
- From:
Journal of Integrative Medicine
2021;19(2):185-190
- CountryChina
- Language:English
-
Abstract:
After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or deterioration of the patient's condition was found within seven weeks of treatment and follow-up, and no adverse events occurred, indicating that oral Chinese medicine decoction was able to improve the pulmonary inflammation and fibrosis in a patient recovering from COVID-19, but further research is still needed.
